Skip to main content

Advertisement

Table 2 Accumulated overall survival (OS) rates (median, mean, 1-, 2-, and 5-year) of de novo prostate cancer patients with bone metastases

From: Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients

Metastatic sitesMedian survival (months)Mean survival (months)1-year (%)2-year (%)5-year (%)
Bone-only2735.8773.653.424.2
Bone and lung2030.7463.244.622.1
Bone and liver1017.3944.522.65.1
Bone and brain1019.1142.023.911.8
Bone and ≥ 2 other sites1120.2345.526.411.4